Research Article
BibTex RIS Cite
Year 2021, , 80 - 87, 04.01.2021
https://doi.org/10.18621/eurj.767468

Abstract

References

  • 1. Fouks Y, Cohen Y, Tulandi T, Meiri A, Levin I, Almog B, et al. Complicated clinical course and poor reproductive outcomes of women with tubo-ovarian abscess after fertility treatments. J Minim Invasive Gynecol 2019;26:162-8.
  • 2. Tao X, Ge SQ, Chen L, Cai LS, Hwang MF, Wang CL. Relationships between female infertility and female genital infections and pelvic inflammatory disease: a population-based nested controlled study. Clinics 2018;73:e364.
  • 3. Fouks Y, Cohen A, Shapira U, Solomon N, Almog B, Levin I. Surgical intervention in patients with tubo-ovarian abscess: clinical predictors and a simple risk score. J Minim Invasive Gynecol 2019;26:535-43.
  • 4. Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015;64:1-137.
  • 5. Brun JL, Graesslin O, Fauconnier A, Verdon R, Agostini A, Bourret A, et al. Updated French guidelines for diagnosis and management of pelvic inflammatory disease. Int J Gynaecol Obstet 2016;134:121-5.
  • 6. Jaiyeoba O, Lazenby G, Soper DE. Recommendations and rationale for the treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther 2011;9:61-70.
  • 7. Chan GMF, Fong YF, Ng KL. Tubo-ovarian abscesses: epidemiology and predictors for failed response to medical management in an Asian population. Infect Dis Obstet Gynecol 2019;2019:4161394.
  • 8. Sexually Transmitted Diseases: Summary of 2015 CDC Treatment Guidelines. J Miss State Med Assoc 2015;56:372-5.
  • 9. Ross J, Judlin P, Jensen J; International Union against sexually transmitted infections. 2012 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS 2014;25:1-7.
  • 10. Henry-Suchet J. Laparoscopic treatment of tubo-ovarian abscess: thirty years' experience. J Am Assoc Gynecol Laparosc 2002;9:235-7.
  • 11. Hsiao SM, Hsieh FJ, Lien YR. Tubo-ovarian abscesses in postmenopausal women. Taiwan J Obstet Gynecol 2006;45:234-8.
  • 12.Rosen M, Breitkopf D, Waud K. Tubo-ovarian abscess management options for women who desire fertility. Obstet Gynecol Surv 2009;64:681-9.
  • 13. Farid H, Lau TC, Karmon AE, Styer AK. Clinical characteristics associated with antibiotic treatment failure for tubo-ovarian abscesses. Infect Dis Obstet Gynecol 2016;2016:5120293.
  • 14. Akkurt MÖ, Yalçın SE, Akkurt İ, Tatar B, Yavuz A, Yalçın Y, et al. The evaluation of risk factors for failed response to conservative treatment in tubo-ovarian abscesses. J Turkish Ger Gynecol Assoc 2015;16:226-30.
  • 15. Venn A, Watson LF, Hemminki E, Healy D, Bruinsma FJ. Mortality in a cohort of IVF patients. Hum Reprod 2001;16:2691-6.
  • 16. Dewitt J, Reining A, Allsworth JE, Peipert JF. Tuboovarian abscesses: is size associated with duration of hospitalization & complications?. Obstet Gynecol Int 2010;2010:847041.
  • 17. Topçu HO, Kokanali K, Güzel AI, Tokmak A, Erkilinç S, Ümit C, et al. Risk factors for adverse clinical outcomes in patients with tubo-ovarian abscess. J Obstet Gynaecol 2015;35:699-702.
  • 18. Facy O, Paquette B, Orry D, Santucci N, Rat P, Rat P, et al. Inflammatory markers as early predictors of infection after colorectal surgery: the same cut-off values in laparoscopy and laparotomy? Int J Colorectal Dis 2017;32:857-63.
  • 19. Jacobi CA, Ordemann J, Zieren HU, Volk HD, Bauhofer A, Halle E, et al. Increased systemic inflammation after laparotomy vs laparoscopy in an animal model of peritonitis. Arch Surg 1998;133:258-62.
  • 20. Protopapas AG, Diakomanolis ES, Milingos SD, Rodolakis AJ, Markaki SN, Vlachos GD, et al. Tubo-ovarian abscesses in postmenopausal women: gynecological malignancy until proven otherwise? Eur J Obstet Gynecol Reprod Biol 2004;114:203-9.
  • 21. Yagur Y, Weitzner O, Man-El G, Schonman R, Klein Z, Fishman A, et al. Conservative management for postmenopausal women with tubo-ovarian abscess. Menopause 2019;26:793-6.
  • 22. Güngördük K, Guzel E, Asicioǧlu O, Yildirim G, Ataser G, Ark C, et al. Experience of tubo-ovarian abscess in western Turkey. Int J Gynecol Obstet 2014;124:45-50.

Outcomes of surgical practice on tubo-ovarian abscess in an academic hospital

Year 2021, , 80 - 87, 04.01.2021
https://doi.org/10.18621/eurj.767468

Abstract

Objectives: We aimed to analyseour experience in the surgical management of tubo-ovarian abscess at a tertiary hospital.


Methods:
Data from patients who underwent laparoscopy or laparotomyfor treatment of tubo-ovarian abscess were retrospectively analyzed. The clinical and surgical outcomes of patients with tubo-ovarian abscess were compared according to the applied surgical approach.


Results:
The mean largest diameter of the abscess in the laparoscopy and laparotomy groups were similar (p = 0.520). The mean day for total antibiotic use was significantly shorter in the laparoscopy group (10.00 ± 4.37 day vs 17.91 ± 6.59 day; p = 0.002). All cases in the laparotomy group needed to change the antibiotic regimen, but it was needed only in 28.58% of patients in the laparoscopy group. However, preoperative fever and pulse rate was significantly higher in laparotomy group than in the laparoscopy group (p = 0.004, p = 0.014; respectively). There was no statistical difference in terms of applied surgical procedure betweenthetwo groups. The most applied surgical procedure was abscess drainage in both of the groups (71.42%, 90.90%; respectively). The median operation time in patients with laparoscopy was statistically shorter than in patients with laparotomy (65.50 [58-93] minutes vs 84 [74-90] minutes, p = 0.048). In comparison of postoperative complications between two groups, there was no statistically significant difference. We observed statistically significant declination in white blood cell count and C-reactive protein values at the postoperative 7th day in all patients (p < 0.001 and p < 0.001, respectively).


Conclusions:
In terms of surgical approach for tubo-ovarian abscess, laparoscopy is more effective than laparotomy for shorter duration of postoperative antibiotic use, operation time and length of hospital stay.

References

  • 1. Fouks Y, Cohen Y, Tulandi T, Meiri A, Levin I, Almog B, et al. Complicated clinical course and poor reproductive outcomes of women with tubo-ovarian abscess after fertility treatments. J Minim Invasive Gynecol 2019;26:162-8.
  • 2. Tao X, Ge SQ, Chen L, Cai LS, Hwang MF, Wang CL. Relationships between female infertility and female genital infections and pelvic inflammatory disease: a population-based nested controlled study. Clinics 2018;73:e364.
  • 3. Fouks Y, Cohen A, Shapira U, Solomon N, Almog B, Levin I. Surgical intervention in patients with tubo-ovarian abscess: clinical predictors and a simple risk score. J Minim Invasive Gynecol 2019;26:535-43.
  • 4. Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015;64:1-137.
  • 5. Brun JL, Graesslin O, Fauconnier A, Verdon R, Agostini A, Bourret A, et al. Updated French guidelines for diagnosis and management of pelvic inflammatory disease. Int J Gynaecol Obstet 2016;134:121-5.
  • 6. Jaiyeoba O, Lazenby G, Soper DE. Recommendations and rationale for the treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther 2011;9:61-70.
  • 7. Chan GMF, Fong YF, Ng KL. Tubo-ovarian abscesses: epidemiology and predictors for failed response to medical management in an Asian population. Infect Dis Obstet Gynecol 2019;2019:4161394.
  • 8. Sexually Transmitted Diseases: Summary of 2015 CDC Treatment Guidelines. J Miss State Med Assoc 2015;56:372-5.
  • 9. Ross J, Judlin P, Jensen J; International Union against sexually transmitted infections. 2012 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS 2014;25:1-7.
  • 10. Henry-Suchet J. Laparoscopic treatment of tubo-ovarian abscess: thirty years' experience. J Am Assoc Gynecol Laparosc 2002;9:235-7.
  • 11. Hsiao SM, Hsieh FJ, Lien YR. Tubo-ovarian abscesses in postmenopausal women. Taiwan J Obstet Gynecol 2006;45:234-8.
  • 12.Rosen M, Breitkopf D, Waud K. Tubo-ovarian abscess management options for women who desire fertility. Obstet Gynecol Surv 2009;64:681-9.
  • 13. Farid H, Lau TC, Karmon AE, Styer AK. Clinical characteristics associated with antibiotic treatment failure for tubo-ovarian abscesses. Infect Dis Obstet Gynecol 2016;2016:5120293.
  • 14. Akkurt MÖ, Yalçın SE, Akkurt İ, Tatar B, Yavuz A, Yalçın Y, et al. The evaluation of risk factors for failed response to conservative treatment in tubo-ovarian abscesses. J Turkish Ger Gynecol Assoc 2015;16:226-30.
  • 15. Venn A, Watson LF, Hemminki E, Healy D, Bruinsma FJ. Mortality in a cohort of IVF patients. Hum Reprod 2001;16:2691-6.
  • 16. Dewitt J, Reining A, Allsworth JE, Peipert JF. Tuboovarian abscesses: is size associated with duration of hospitalization & complications?. Obstet Gynecol Int 2010;2010:847041.
  • 17. Topçu HO, Kokanali K, Güzel AI, Tokmak A, Erkilinç S, Ümit C, et al. Risk factors for adverse clinical outcomes in patients with tubo-ovarian abscess. J Obstet Gynaecol 2015;35:699-702.
  • 18. Facy O, Paquette B, Orry D, Santucci N, Rat P, Rat P, et al. Inflammatory markers as early predictors of infection after colorectal surgery: the same cut-off values in laparoscopy and laparotomy? Int J Colorectal Dis 2017;32:857-63.
  • 19. Jacobi CA, Ordemann J, Zieren HU, Volk HD, Bauhofer A, Halle E, et al. Increased systemic inflammation after laparotomy vs laparoscopy in an animal model of peritonitis. Arch Surg 1998;133:258-62.
  • 20. Protopapas AG, Diakomanolis ES, Milingos SD, Rodolakis AJ, Markaki SN, Vlachos GD, et al. Tubo-ovarian abscesses in postmenopausal women: gynecological malignancy until proven otherwise? Eur J Obstet Gynecol Reprod Biol 2004;114:203-9.
  • 21. Yagur Y, Weitzner O, Man-El G, Schonman R, Klein Z, Fishman A, et al. Conservative management for postmenopausal women with tubo-ovarian abscess. Menopause 2019;26:793-6.
  • 22. Güngördük K, Guzel E, Asicioǧlu O, Yildirim G, Ataser G, Ark C, et al. Experience of tubo-ovarian abscess in western Turkey. Int J Gynecol Obstet 2014;124:45-50.
There are 22 citations in total.

Details

Primary Language English
Subjects Obstetrics and Gynaecology
Journal Section Original Articles
Authors

Burak Sezgin 0000-0003-2938-5816

Melike Nur Akın 0000-0001-6794-846X

Burcu Kasap 0000-0002-1768-5320

Publication Date January 4, 2021
Submission Date July 13, 2020
Acceptance Date August 27, 2020
Published in Issue Year 2021

Cite

AMA Sezgin B, Akın MN, Kasap B. Outcomes of surgical practice on tubo-ovarian abscess in an academic hospital. Eur Res J. January 2021;7(1):80-87. doi:10.18621/eurj.767468

e-ISSN: 2149-3189 


The European Research Journal, hosted by Turkish JournalPark ACADEMIC, is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

by-nc-nd.png

2025